ArticleBreast cancer research : BCR2026

Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancer.

Nickolas Stabellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.